Navigation Links
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
Date:5/8/2008

New imaging modality highlights Volcano commitment to intravascular imaging

and opens up new clinical and research applications

SAN DIEGO and BRUSSELS, Belgium, May 8 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer and developer of intravascular ultrasound (IVUS), functional measurement (FM) and Optical Coherence Tomography (OCT) products designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today the first human procedure using the Volcano OCT Imaging catheter. The procedure was performed by Dr. Patrick Serruys at the Thoraxcenter, in Rotterdam, Netherlands. Volcano OCT will complement its existing line of IVUS imaging catheters and pressure guidewires used for coronary imaging and lesion assessment.

Volcano acquired the OCT technology through its purchase of CardioSpectra at the end of 2007.

Scott Huennekens, President and Chief Executive Officer of Volcano, commented, "Volcano is committed to being the leader in intravascular imaging, both to complement everyday PCI technique, and to further the understanding of atherosclerotic disease progression. Our investment in this OCT product line underscores that commitment, and opens a series of new clinical applications and opportunities to complement our existing product line. We are delighted to be underway with our OCT effort just four months after completing the acquisition.

"With our two imaging technologies, we are the leader in intravascular imaging and commercializing this technology will provide us further competitive advantages. We are working on offerings that incorporate OCT functionality into our s5i IVUS platform, as well as standalone OCT systems. Our emph
'/>"/>

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Announces Closing of CardioSpectra Acquisition
5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
6. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
9. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)... Johnson & Johnson today a... Department of Molecular Biology at the Max Planck...veries have led to novel cancer therapies includin...e 2009 Dr. Paul Janssen Award for Biomedical Resea...ientists selected Dr. Ullrich, who on September 8 ...
(Date:7/1/2009)... first stimulant to establish duration of efficacy...n in adults with ADHD , , HOLLYWOOD, Fla., July...Nasdaq: SHPGY ), the global specialty biopharmac...ase 3b study that found VYVANSE(R) (lisdexamfetami...cy at 14 hours after administration during a simul...
(Date:7/1/2009)... 1 NeoStem, Inc. (NYSE A...ditional gross funds of over $4 million from insti...her with the $11 million private placement from th... bring the total investment obtained by NeoStem in... In addition, affiliates of Suzhou Erye Pharmaceu...
(Date:7/1/2009)..., Germany, July 1 Gerres...plastic products for the pharma & life,scienc...ions, which are not,part of the MDAX company,s co.... "Through the sale of the Technical Plastics segm...ken a further step in its focus on the core,busin...
Breaking Biology Technology:Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 3Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 2Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 3Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 4Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 6Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 7Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 8NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 2NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 3Gerresheimer Sells Technical Plastics Business 2
... Carl Christensen is a featured speaker at the D... electronic health records. In the last decade, te...rmation has become hot enough to raise a new term,...he Marshfield Clinic , they didn,t wait for that ...dical informatics associations and journals began ...
... In a long-planned departure from its traditional ...c Engineering has contracted with the U.S. Army fo...based in Eau Claire, announced today that it has s...l year 2005. The company has been working with the...nd (CERDEC) to develop a low-cost battery life ind...
... Middleton, Wis. Bone Care International, Inc....llion in profits on $22 million in sales for the q...based drug used to lower abnormally high levels of...ey disease. Gross margins run about 75 percent. , ...y from the same quarter last year, when it reporte...
... Madison, Wis. Representatives of the British C...io and health technology investments, met Wisconsi...pportunities for collaboration. , ,"We,re looking ...imentary technologies," said Frank Phillips, vice ...ulate-General . "Oftentimes the partnership can le...
Other Biology Technology:Carl Christensen says Marshfield Clinic's history gives it an IT edge 2Carl Christensen says Marshfield Clinic's history gives it an IT edge 3Carl Christensen says Marshfield Clinic's history gives it an IT edge 4SLE of Eau Claire lands $2.2 million in federal contracts 2SLE of Eau Claire lands $2.2 million in federal contracts 3British, Wisconsin firms explore life-science opportunities together 2British, Wisconsin firms explore life-science opportunities together 3
(Date:7/2/2009)...09 Researchers at Ben-Gurion University of the Ne... once helped humans survive may increase the possi...ngs were recently the cover story in the journal ...GU,s National Institute for Biotechnology in the N...enome of the mitochondria, a part of every cell re...
(Date:7/2/2009)... organisms and a domain unto themselves, quite apa...nd higher organisms. Many species live under extre...ocesses shared neither with bacteria nor with euka...roduce methane gas out of carbon dioxide and hydro..., involves the cofactor known as F0 or F420 which ...
(Date:7/2/2009)...up of proteins that are highly effective at killin...ing new types of antibiotics. , Researchers from...ded 3.3m from the Biotechnology and Biological Sci...amily of proteins known as colicins force their wa... The team, led by Professor Colin Kleanthous, from...
(Date:7/1/2009)...gue, Ebola and Rift Valley Fever are being targete...al partnership involving African researchers and t... The Southern African Centre for Infectious Diseas...ry institutions from five African countries and th...ns to detect, identify and monitor infectious dise...
Breaking Biology News(10 mins):Ben-Gurion U. researchers reveal connection between cancer and human evolution 2Rampant helper syndrome 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 2Research network wins approximately £5.7 million to target human and animal diseases in Africa 3Quantros President Appears on National TV Promoting Patient Safety 36974 1Quantros President Appears on National TV Promoting Patient Safety 36974 2Albany High School Students Unite To Raise Awareness and Funds For World Rare Disease Day 2009 36969 1Albany High School Students Unite To Raise Awareness and Funds For World Rare Disease Day 2009 36969 2Albany High School Students Unite To Raise Awareness and Funds For World Rare Disease Day 2009 36969 3Frost 26 Sullivan 3A Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing 36964 1Frost 26 Sullivan 3A Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing 36964 2Thomson Reuters Releases 2009 Patent Focus Report 36962 1Thomson Reuters Releases 2009 Patent Focus Report 36962 2
...ve shown for the first time how histatin, the natu...the oral pathogen Candida albicans, the fungus res...Researchers led by Mira Edgerton, D.D.S., Ph.D., d...ne protein called TRK1p, which regulates potassium...nic fungus Candida albicans and allows the cell to...
...sponse to bacterial invasion is to increase nitric...ic oxide synthase. In a study published in the Jou...at the predominantly anti-inflammatory enzyme, end...n nitric oxide production in response to infection...et to treat sepsis, which is caused by overproduct...
... by which hematopoietic stem cells (HSC) give rise...d platelets has now been discovered to depend in l...inding, from an investigator at St. Jude Children,...18 issue of Science. , Mcl-1 blocks the biochemica...ll suicide") of HSCs, according to Joseph Opferman...
...ld Wildlife Fund and its partners in the Internati...nning solutions to prevent the accidental maiming ...sea turtles that become ensnared by fishing nets a...so improving the efficiency of commercial fishing....said Carter Roberts, president and CEO-elect, Worl...
Other Biology News:Discovery may lead to better Candidiasis drug 2Researchers report new pro-inflammatory role for anti-inflammatory enzyme 2Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis 2Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis 3Solutions that reduce death of marine life reeled in by International Smart Gear Competition 2Solutions that reduce death of marine life reeled in by International Smart Gear Competition 3
Request Info
...munogen: Synthetic peptide derived from the intern...y: Specific for the junctophilin-1 protein. React...keletal muscle homogenates frozen mouse brain and ...lotting Immunohistochemistry(froz) Immunofluoresce...
...w Stem Cell Antibody Panels to its expanding line ...ll Marker Antibody Panel (Catalog # SC008) contain...nog, Oct-3/4, SSEA-1 and SSEA-4. The Human Embryon... SC009) contains antibodies against: CD9, E-Cadher...
Epstein-Barr Virus (EBV) (EBNA-1)
Biology Products: